Albanell-Fernández, M.; Oltra, S.S.; Orts-Arroyo, M.; Ibarrola-Villava, M.; Carrasco, F.; Jiménez-MartÃ, E.; Cervantes, A.; Castro, I.; MartÃnez-Lillo, J.; Ribas, G.
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers 2023, 15, 69.
https://doi.org/10.3390/cancers15010069
AMA Style
Albanell-Fernández M, Oltra SS, Orts-Arroyo M, Ibarrola-Villava M, Carrasco F, Jiménez-Martà E, Cervantes A, Castro I, MartÃnez-Lillo J, Ribas G.
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers. 2023; 15(1):69.
https://doi.org/10.3390/cancers15010069
Chicago/Turabian Style
Albanell-Fernández, Marta, Sara S. Oltra, Marta Orts-Arroyo, Maider Ibarrola-Villava, Fany Carrasco, Elena Jiménez-MartÃ, Andrés Cervantes, Isabel Castro, José MartÃnez-Lillo, and Gloria Ribas.
2023. "RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines" Cancers 15, no. 1: 69.
https://doi.org/10.3390/cancers15010069
APA Style
Albanell-Fernández, M., Oltra, S. S., Orts-Arroyo, M., Ibarrola-Villava, M., Carrasco, F., Jiménez-MartÃ, E., Cervantes, A., Castro, I., MartÃnez-Lillo, J., & Ribas, G.
(2023). RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines. Cancers, 15(1), 69.
https://doi.org/10.3390/cancers15010069